You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: P3.06 Les toxidermies à l’imatinib. Etude retrospective a propos de 28 cas

€2.42

SKU: product-article-19571 Category: General

Description

Description

P3.06 Les toxidermies à l’imatinib. Etude retrospective a propos de 28 cas

Top

Article: P3.06 Les toxidermies à l’imatinib. Etude retrospective a propos de 28 cas

Description

Related products

Article: Highlights in urologic cancer

Article: INTRODUCTION

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in gynaecological cancers